Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+52Cutaneous Melanoma+24Malignant Laryngeal Neoplasm+24Malignant Bladder Neoplasm+20Malignant Esophageal Neoplasm+16Malignant Pancreatic Neoplasm+12Malignant Prostate Neoplasm+12Malignant Salivary Gland Neop…+12Malignant Kidney Neoplasm+8Malignant Mesothelioma+8Malignant Testicular Neoplasm+8Malignant Hypopharyngeal Neop…0Malignant Lung Neoplasm0Malignant Penile Neoplasm0Hodgkin Lymphoma-4
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+52100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
23491
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
92
activityPercentile
40

ranking row 2593161

2=Cutaneous Melanoma+2496Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4763
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
48
activityPercentile
24

ranking row 2593162

2=Malignant Laryngeal Neoplasm+2496Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3018
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
40
activityPercentile
16

ranking row 2593163

4=Malignant Bladder Neoplasm+2088Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
8343
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
68
activityPercentile
48

ranking row 2593164

5=Malignant Esophageal Neoplasm+1684Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
9606
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
76
activityPercentile
60

ranking row 2593165

6=Malignant Pancreatic Neoplasm+1280Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14466
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
88
activityPercentile
76

ranking row 2593166

6=Malignant Prostate Neoplasm+1280Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
30719
formula
percentile(mortality_count) − percentile(active_trials)
activity
1375
burdenPercentile
96
activityPercentile
84

ranking row 2593168

6=Malignant Salivary Gland Neoplasm+1280Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
419
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
24
activityPercentile
12

ranking row 2593167

9=Malignant Kidney Neoplasm+868Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
7524
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
64
activityPercentile
56

ranking row 2593170

9=Malignant Mesothelioma+868Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1907
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
36
activityPercentile
28

ranking row 2593169

9=Malignant Testicular Neoplasm+868Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
335
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
12
activityPercentile
4

ranking row 2593171

12=Malignant Hypopharyngeal Neoplasm056Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
257
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
8
activityPercentile
8

ranking row 2593173

12=Malignant Lung Neoplasm056Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
90363
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2593172

12=Malignant Penile Neoplasm056Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
205
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
4
activityPercentile
4

ranking row 2593174

15=Hodgkin Lymphoma-444Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
725
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
32
activityPercentile
36

ranking row 2593176

15=Leukemia-444Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11894
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
84
activityPercentile
88

ranking row 2593175

15=Malignant Gastric Neoplasm-444Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
7191
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
60
activityPercentile
64

ranking row 2593177

15=Malignant Thyroid Gland Neoplasm-444Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
568
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
28
activityPercentile
32

ranking row 2593178

19=Malignant Liver Neoplasm-828Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
8483
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
72
activityPercentile
80

ranking row 2593179

19=Malignant Rectal Neoplasm-828Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4738
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
44
activityPercentile
52

ranking row 2593180

21=Non-Hodgkin Lymphoma-1220Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11710
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
80
activityPercentile
92

ranking row 2593181

22=Malignant Central Nervous System Neoplasm-1616Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
7015
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
56
activityPercentile
72

ranking row 2593182

22=Multiple Myeloma-1616Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
5480
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
52
activityPercentile
68

ranking row 2593183

24=Malignant Anal Neoplasm-208Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
185
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
0
activityPercentile
20

ranking row 2593184

25=Malignant Nasopharyngeal Neoplasm-244Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
415
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
20
activityPercentile
44

ranking row 2593185

26=Malignant Breast Neoplasm-760Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
415
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
20
activityPercentile
96

ranking row 2593186

Data updated 16 hours agoSource updated unknown26 eligible entities · inputs hash 9d0a53ec17f20817ef648a30